Table of contents
- Navigating new FDA and Health Canada advertising regulations
- FDA approach on promotional compliance in the US
- Health Canada’s approach to compliance in advertising
- Responsible bodies for compliance of advertising and promotional material
- Impact on pharmaceutical companies and regulatory professionals in North America
- Key strategies for compliance with OPDP guidelines and PAAB Code